RESEARCHDIAGNOSTICSTRANSLATIONOUTREACH
 
Sara Ricardo
Name: Sara Ricardo
E-mail: sricardo@ipatimup.pt
Extension: 
225570700
Academic Degree: Doctor of philosophy


Sara Ricardo
Sara Ricardo
Member of
Junior Researcher of Differentiation and cancer


Short CV
ACADEMIC PATH
2007-2011. Doctorate degree in Molecular Pathology and Genetics from the Institute of Biomedical Science Abel Salazar of the University of Porto.
2003-2005. Master degree in Molecular Oncology from the Medical faculty of the University of Porto.
1998-2002. Bachelor degree in Anatomical Pathology, Cytology and Thanatology from the Superior Scholl of Health technology of Lisbon (1998-2001) and Porto (2001-2002)

PROFESSIONAL AND SCIENTIFIC EXPERIENCE
Since November 2012. Research fellowship in the Carcinogenesis, supervised by Prof. Leonor David, in the project ""Mucin MUC16 - CA125 cancer biomarker - biological functions and development of new biomarker assays""
Since 2004. Invited professor in the Superior Scholl of Health Cadences of Vale do Sousa.
Since 2002 - August 2012. Pathology Technician in the Diagnosis Unit of Ipatimup.
Since 2003 - August 2012. Member of the Cancer Genetics research group of Ipatimup, supervised by Prof. Fernando Schmitt and Doctor Joana Paredes.


Highlights
""Mucin MUC16 - CA125 cancer biomarker - biological functions and development of new biomarker assays""

Supervisor of
Mariana Nunes, Fellow

PI (running)

PI (closed)
First Author
 
C
IF
1. Ricardo S, Marcos-Silva L, Valente C, Coelho R, Gomes R, David L
Mucins MUC16 and MUC1 are major carriers of SLe(a) and SLe(x) in borderline and malignant serous ovarian tumors. Virchows Archiv : an international journal of pathology 468: 715-22, 2016. [Article] 
 doi: 10.1007/s00428-016-1929-6 PMID: 27003157.
 
6
2.8
2. Ricardo S, Marcos-Silva L, David L
Mucin carriers of TF in ovarian cancer. Journal of cancer research and clinical oncology 142: 1867-8, 2016. [Letter] 
 doi: 10.1007/s00432-016-2186-4 PMID: 27277091.
 
0
3.5
3. Ricardo S, Marcos-Silva L, Pereira D, Pinto R, Almeida R, Söderberg O, Mandel U, Clausen H, Felix A, Lunet N, David L
Detection of glyco-mucin profiles improves specificity of MUC16 and MUC1 biomarkers in ovarian serous tumours. Molecular oncology 9: 503-12, 2015. [Article] 
 doi: 10.1016/j.molonc.2014.10.005 PMID: 25454345.
 
25
5.4
4. Ricardo S, Gerhard R, Cameselle-Teijeiro JF, Schmitt F, Paredes J
Claudin expression in breast cancer: High or low, what to expect? Histology and histopathology 27: 1283-95, 2012. [Article] 
 PMID: 22936447.
 
10
2.3
5. Ricardo S, Vieira AF, Gerhard R, Leitão D, Pinto R, Cameselle-Teijeiro JF, Milanezi F, Schmitt F, Paredes J
Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype. Journal of clinical pathology 64: 937-46, 2011. [Article] 
 doi: 10.1136/jcp.2011.090456 PMID: 21680574.
 
256
2.3
6. Ricardo SA, Milanezi F, Carvalho ST, Leitão DR, Schmitt FC
HER2 evaluation using the novel rabbit monoclonal antibody SP3 and CISH in tissue microarrays of invasive breast carcinomas. Journal of clinical pathology 60: 1001-5, 2007. [Article] 
 doi: 10.1136/jcp.2006.040287 PMID: 17158643.
 
39
2.4
Senior Author
 
C
IF
1. Coelho R, Marcos-Silva L, Mendes N, Pereira D, Brito C, Jacob F, Steentoft C, Mandel U, Clausen H, David L, Ricardo S
Mucins and Truncated O-Glycans Unveil Phenotypic Discrepancies between Serous Ovarian Cancer Cell Lines and Primary Tumours. International journal of molecular sciences 19: ., 2018. [Article] 
 doi: 10.3390/ijms19072045 PMID: 30011875.
 
5
3.7 (*)
@ 2014 Ipatimup Institute of Molecular Pathology and Immunology of the University of Porto
A
A
A

Send Email
From
To
Subject